What is the current valuation of the food allergy diagnosis and treatment market?

The market valuation was 32.5 USD Billion in 2024. Read More

What is the projected market size for the food allergy diagnosis and treatment market by 2035?

The market is projected to reach 55.7 USD Billion by 2035. Read More

What is the expected CAGR for the food allergy diagnosis and treatment market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 5.02%. Read More

Which companies are considered key players in the food allergy diagnosis and treatment market?

Key players include Thermo Fisher Scientific, Abbott Laboratories, Danone, Nestle, Bayer AG, Mylan N.V., Aimmune Therapeutics, Allergan, and Horizon Therapeutics. Read More

What are the main applications in the food allergy diagnosis and treatment market?

Main applications include Skin Testing, Blood Testing, Oral Food Challenge, and Patch Testing. Read More

How much revenue is generated from blood testing in the food allergy diagnosis and treatment market?

Blood Testing generated revenues of 10.0 USD Billion in 2024 and is projected to reach 16.0 USD Billion by 2035. Read More

What is the revenue outlook for hospitals as an end-use segment in the food allergy diagnosis and treatment market?

Hospitals generated 10.0 USD Billion in 2024 and are expected to reach 17.0 USD Billion by 2035. Read More

Which type of allergy generates the highest revenue in the market?

Shellfish Allergy generated 10.5 USD Billion in 2024 and is projected to reach 19.4 USD Billion by 2035. Read More

What are the projected revenues for specific IgE testing by 2035?

Specific IgE Testing is expected to generate revenues of 10.2 USD Billion in 2024 and reach 17.0 USD Billion by 2035. Read More

How does the food allergy diagnosis and treatment market's growth compare across different diagnosis methods?

The market for diagnosis methods shows varied growth, with Skin Prick Test projected to grow from 8.1 USD Billion in 2024 to 13.5 USD Billion by 2035. Read More

Food Allergy Diagnosis Treatment Market

ID: MRFR/HC/6093-CR

123 Pages

Vikita Thakur

Last Updated: May 15, 2026

Food Allergy Diagnosis and Treatment Market Research Report By Diagnosis Method (Skin Prick Test, Blood Test, Oral Food Challenge, Elimination Diet), By Treatment Type (Medication, Immunotherapy, Dietary Management, Emergency Treatment Devices), By End User (Hospitals, Clinics, Home Care, Pharmaceutical Companies), By Age Group (Children, Adults, Elderly) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Billion)
  1. 4.1.1 Skin Testing
  2. 4.1.2 Blood Testing
  3. 4.1.3 Oral Food Challenge
  4. 4.1.4 Patch Testing
2. 4.2 Healthcare, BY End Use (USD Billion)
  1. 4.2.1 Hospitals
  2. 4.2.2 Diagnostic Laboratories
  3. 4.2.3 Home Care Settings
  4. 4.2.4 Research Institutions
3. 4.3 Healthcare, BY Type of Allergy (USD Billion)
  1. 4.3.1 Peanut Allergy
  2. 4.3.2 Milk Allergy
  3. 4.3.3 Egg Allergy
  4. 4.3.4 Shellfish Allergy
4. 4.4 Healthcare, BY Diagnosis Method (USD Billion)
  1. 4.4.1 Skin Prick Test
  2. 4.4.2 Specific IgE Testing
  3. 4.4.3 Component Resolved Diagnostics
  4. 4.4.4 Elimination Diet
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Abbott Laboratories (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Danone (FR)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Nestle (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bayer AG (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Mylan N.V. (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Aimmune Therapeutics (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Allergan (IE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Horizon Therapeutics (IE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY END USE
5. 6.5 US MARKET ANALYSIS BY TYPE OF ALLERGY
6. 6.6 US MARKET ANALYSIS BY DIAGNOSIS METHOD
7. 6.7 CANADA MARKET ANALYSIS BY APPLICATION
8. 6.8 CANADA MARKET ANALYSIS BY END USE
9. 6.9 CANADA MARKET ANALYSIS BY TYPE OF ALLERGY
10. 6.10 CANADA MARKET ANALYSIS BY DIAGNOSIS METHOD
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY APPLICATION
13. 6.13 GERMANY MARKET ANALYSIS BY END USE
14. 6.14 GERMANY MARKET ANALYSIS BY TYPE OF ALLERGY
15. 6.15 GERMANY MARKET ANALYSIS BY DIAGNOSIS METHOD
16. 6.16 UK MARKET ANALYSIS BY APPLICATION
17. 6.17 UK MARKET ANALYSIS BY END USE
18. 6.18 UK MARKET ANALYSIS BY TYPE OF ALLERGY
19. 6.19 UK MARKET ANALYSIS BY DIAGNOSIS METHOD
20. 6.20 FRANCE MARKET ANALYSIS BY APPLICATION
21. 6.21 FRANCE MARKET ANALYSIS BY END USE
22. 6.22 FRANCE MARKET ANALYSIS BY TYPE OF ALLERGY
23. 6.23 FRANCE MARKET ANALYSIS BY DIAGNOSIS METHOD
24. 6.24 RUSSIA MARKET ANALYSIS BY APPLICATION
25. 6.25 RUSSIA MARKET ANALYSIS BY END USE
26. 6.26 RUSSIA MARKET ANALYSIS BY TYPE OF ALLERGY
27. 6.27 RUSSIA MARKET ANALYSIS BY DIAGNOSIS METHOD
28. 6.28 ITALY MARKET ANALYSIS BY APPLICATION
29. 6.29 ITALY MARKET ANALYSIS BY END USE
30. 6.30 ITALY MARKET ANALYSIS BY TYPE OF ALLERGY
31. 6.31 ITALY MARKET ANALYSIS BY DIAGNOSIS METHOD
32. 6.32 SPAIN MARKET ANALYSIS BY APPLICATION
33. 6.33 SPAIN MARKET ANALYSIS BY END USE
34. 6.34 SPAIN MARKET ANALYSIS BY TYPE OF ALLERGY
35. 6.35 SPAIN MARKET ANALYSIS BY DIAGNOSIS METHOD
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY END USE
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY TYPE OF ALLERGY
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY DIAGNOSIS METHOD
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY APPLICATION
42. 6.42 CHINA MARKET ANALYSIS BY END USE
43. 6.43 CHINA MARKET ANALYSIS BY TYPE OF ALLERGY
44. 6.44 CHINA MARKET ANALYSIS BY DIAGNOSIS METHOD
45. 6.45 INDIA MARKET ANALYSIS BY APPLICATION
46. 6.46 INDIA MARKET ANALYSIS BY END USE
47. 6.47 INDIA MARKET ANALYSIS BY TYPE OF ALLERGY
48. 6.48 INDIA MARKET ANALYSIS BY DIAGNOSIS METHOD
49. 6.49 JAPAN MARKET ANALYSIS BY APPLICATION
50. 6.50 JAPAN MARKET ANALYSIS BY END USE
51. 6.51 JAPAN MARKET ANALYSIS BY TYPE OF ALLERGY
52. 6.52 JAPAN MARKET ANALYSIS BY DIAGNOSIS METHOD
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY END USE
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY TYPE OF ALLERGY
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY DIAGNOSIS METHOD
57. 6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION
58. 6.58 MALAYSIA MARKET ANALYSIS BY END USE
59. 6.59 MALAYSIA MARKET ANALYSIS BY TYPE OF ALLERGY
60. 6.60 MALAYSIA MARKET ANALYSIS BY DIAGNOSIS METHOD
61. 6.61 THAILAND MARKET ANALYSIS BY APPLICATION
62. 6.62 THAILAND MARKET ANALYSIS BY END USE
63. 6.63 THAILAND MARKET ANALYSIS BY TYPE OF ALLERGY
64. 6.64 THAILAND MARKET ANALYSIS BY DIAGNOSIS METHOD
65. 6.65 INDONESIA MARKET ANALYSIS BY APPLICATION
66. 6.66 INDONESIA MARKET ANALYSIS BY END USE
67. 6.67 INDONESIA MARKET ANALYSIS BY TYPE OF ALLERGY
68. 6.68 INDONESIA MARKET ANALYSIS BY DIAGNOSIS METHOD
69. 6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION
70. 6.70 REST OF APAC MARKET ANALYSIS BY END USE
71. 6.71 REST OF APAC MARKET ANALYSIS BY TYPE OF ALLERGY
72. 6.72 REST OF APAC MARKET ANALYSIS BY DIAGNOSIS METHOD
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY APPLICATION
75. 6.75 BRAZIL MARKET ANALYSIS BY END USE
76. 6.76 BRAZIL MARKET ANALYSIS BY TYPE OF ALLERGY
77. 6.77 BRAZIL MARKET ANALYSIS BY DIAGNOSIS METHOD
78. 6.78 MEXICO MARKET ANALYSIS BY APPLICATION
79. 6.79 MEXICO MARKET ANALYSIS BY END USE
80. 6.80 MEXICO MARKET ANALYSIS BY TYPE OF ALLERGY
81. 6.81 MEXICO MARKET ANALYSIS BY DIAGNOSIS METHOD
82. 6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION
83. 6.83 ARGENTINA MARKET ANALYSIS BY END USE
84. 6.84 ARGENTINA MARKET ANALYSIS BY TYPE OF ALLERGY
85. 6.85 ARGENTINA MARKET ANALYSIS BY DIAGNOSIS METHOD
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF ALLERGY
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY DIAGNOSIS METHOD
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY END USE
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF ALLERGY
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY DIAGNOSIS METHOD
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY END USE
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF ALLERGY
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY DIAGNOSIS METHOD
99. 6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION
100. 6.100 REST OF MEA MARKET ANALYSIS BY END USE
101. 6.101 REST OF MEA MARKET ANALYSIS BY TYPE OF ALLERGY
102. 6.102 REST OF MEA MARKET ANALYSIS BY DIAGNOSIS METHOD
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY END USE, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY TYPE OF ALLERGY, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY TYPE OF ALLERGY, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY DIAGNOSIS METHOD, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY DIAGNOSIS METHOD, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.2.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.2.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.2.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.3.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.3.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.3.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.4.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.4.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.4.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.5.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.5.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.5.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.6.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.6.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.6.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.7.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.7.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.7.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.8.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.8.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.8.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.9.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.9.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.9.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.10.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.10.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.10.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.11.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.11.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.11.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.12.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.12.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.12.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.13.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.13.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.13.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.14.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.14.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.14.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.15.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.15.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.15.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.16.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.16.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.16.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.17.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.17.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.17.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.18.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.18.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.18.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.19.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.19.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.19.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.20.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.20.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.20.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.21.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.21.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.21.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.22.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.22.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.22.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.23.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.23.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.23.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.24.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.24.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.24.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.25.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.25.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.25.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.26.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.26.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.26.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.27.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.27.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.27.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.28.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.28.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.28.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.29.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.29.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.29.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.30.2 BY END USE, 2025-2035 (USD Billion)
  3. 7.30.3 BY TYPE OF ALLERGY, 2025-2035 (USD Billion)
  4. 7.30.4 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Food Allergy Diagnosis Treatment Market Segmentation

Food Allergy Diagnosis Treatment Market By Application (USD Billion, 2025-2035)

Skin Testing
Blood Testing
Oral Food Challenge
Patch Testing

Food Allergy Diagnosis Treatment Market By End Use (USD Billion, 2025-2035)

Hospitals
Diagnostic Laboratories
Home Care Settings
Research Institutions

Food Allergy Diagnosis Treatment Market By Type of Allergy (USD Billion, 2025-2035)

Peanut Allergy
Milk Allergy
Egg Allergy
Shellfish Allergy

Food Allergy Diagnosis Treatment Market By Diagnosis Method (USD Billion, 2025-2035)

Skin Prick Test
Specific IgE Testing
Component Resolved Diagnostics
Elimination Diet

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”